Nafarelin
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB00666 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 20 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | Ambras type hypertrichosis universalis congenita | KG + DL |
| 2 | malformation syndrome with odontal and/or periodontal component | KG + DL |
| 3 | hypertrichosis (disease) | KG + DL |
| 4 | pelvic organ prolapse | KG + DL |
| 5 | syndrome with a Dandy-Walker malformation as major feature | KG + DL |
| 6 | female genital tuberculosis | KG + DL |
| 7 | physiological sexual disorder | KG + DL |
| 8 | isolated genetic hair shaft abnormality | KG + DL |
| 9 | centra precocious puberty 1 | KG + DL |
| 10 | dysplasia of cervix | KG + DL |
| 11 | acne (disease) | KG + DL |
| 12 | idiopathic central precocious puberty | KG + DL |
| 13 | precocious puberty, central, 2 | KG + DL |
| 14 | sex differentiation disease | KG + DL |
| 15 | amenorrhea (disease) | KG + DL |
| 16 | zinc, elevated plasma | KG + DL |
| 17 | ACTH-independent macronodular adrenal hyperplasia | KG + DL |
| 18 | familial isolated trichomegaly | KG + DL |
| 19 | habitual spontaneous abortion | KG + DL |
| 20 | Cushing syndrome due to macronodular adrenal hyperplasia | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.